The sound-alike and look-alike (SALA) drug is one of the most common causes of medication error and is of fear globally. Thus, the probability for error due to confusing drug names is very high. The SALA drug names have become a significant challenge to pharmacists, nurses, patients, and doctors . With thousands of drugs currently on the market, the probability for error is significant. The purpose of this article is to formulate a policy that would help in minimizing medication errors arising with the use of SALA medications.
INTRODUCTION

Sound-alike and Lool-alike Medications
Medication names that sound similar are identified as sound-alike medications and medication names in which packaging is visually similar to another product or medication are identified as look-alike medications. 1 Sound-alike medications are those for which generic or trade names of the product or medication sound similar in the spoken or written words. Thus, they have a high potential for medication error.
Human factor concepts that are relevant to the medication use process are simplicity, standardization, differentiation, lack of duplication, and unambiguous communication.
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NEED OF THE POLICY
The SALA medications create serious problems in health care, leading to 29% of medication dispensing errors. Approximately 25% of errors reported to national medication error reporting programs is the aftermath of confusion with drug names that sound alike and look alike. 3, 4 
MATERIALS AND METHODS
This was a descriptive cross-sectional study carried between March 2016 and March 2017. The study population included doctors, nursing personnel, pharmacists, and quality managers from tertiary care hospitals of both public and private hospitals of India. Checklist was made after an exhaustive review of literature, which was then improvised. Validation of the checklist was done by experts in quality assurance from the National Accreditation Board for Hospitals and Health care Providers-accredited private hospitals. Subsequently, interaction was done with study population against the backdrop of the checklist and policy was formulated.
ANALYSIS AND RESULTS
Two hundred people which included doctors, nurses, pharmacists, and quality managers of tertiary care public and private hospitals were approached for interaction against the backdrop of the check list. Total response rate was 60%. A total of 25 responded out of 50 doctors approached, 35 nurses responded out of 50, 24 quality managers interacted out of 50, and 36 pharmacists responded out of 50 approached. Policy was framed after incorporating inputs from responses received against the backdrop of the checklist.
AIM
The aim of the policy is to augment awareness among health care providers with regard to potential for medication errors due to SALA drugs, hence minimizing medication error.
OBJECTIVES
• To identify SALA medications, i.e., the drugs which have higher potential of medication error due to similarities in their nomenclature (generic/brand name) or their looks (in packaging).
• To increase awareness among health care providers regarding SALA medications.
• To minimize medication errors arising with the use of SALA medications.
• To ensure ordering, storing, handling, and administration of SALA medications in a standardized manner.
SCOPE
• All areas of the health care facility where pharmacy is stored.
• All patient care areas of the hospital.
RESPONSIBILITIES
Pharmacist
Nursing staff Clinicians
POLICY
Strategies to Monitor SALA Drugs 3,5-8
• List of SALA medications to be prepared by the pharmacy of the health care facility. The list needs to be updated every 6 months.
• The list is to be prepared in two sets (Set 1 and Set 2) and drugs are stored in two separate racks/containers accordingly intended to avoid medication error due to close proximity of two SALA medications.
• To evade medication error, while dealing with SALA drugs, tall-man lettering should be practiced. In tallman lettering, part of a drug's name should be in upper case letters to distinguish SALA drugs from one another in order to avoid medication errors (e.g., predniSONE/predniSOLONE).
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• Generic names should also be included in the list of SALA drugs for reconfirming the selection of right medication.
• All nursing stations, treatment rooms, and other patient care area should have the list of SALA medications.
• Any query regarding SALA drugs should be answered by the pharmacy/clinicians at the earliest with correct information.
How to Store SALA Drugs 3,5-8
• The SALA medications should not be stocked up along with other medications, anywhere in the hospital.
• The SALA medications should be stored separately in two racks in the pharmacy store, Group I medications in one rack and group II medications in the other rack to avoid medication error. • In the wards, emergency, and operation theater, the SALA drugs should be stored in separate drug bins or plastic boxes.
• In the pharmacy stores, the list of SALA medications should be hanging from both racks. • In the ward/unit, the list should be pasted inside medication room, if required, on nursing station.
Standardizing Warning Signage 10
Warning stickers pink in color and stating Sound-alike or Look-alike Medications need to be pasted on the storage racks in pharmacy.
In the ward/unit, emergency, or operation theater, cupboards storing the SALA drugs should have the pink colored SALA medication warning label/sticker outside the cupboard.
Inside the cupboard storing SALA drugs, the containers storing groups I and II SALA medications should have pink colored SALA warning sticker.
How to Standardize Ordering/Prescription of SALA Drugs
• While prescribing SALA medications, CAPITAL LETTERS should always be used and handwriting should be clear and legible.
• While ordering or prescribing SALA medications manually, both the brand and the generic name should be documented in the medication chart.
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• Formulary should be accessible to clinicians and staff nurses and facility should be provided for confirming -Generic name from a brand name or -Available brand names from a generic name • Before documenting the prescription -There should be readback confirmation of the drug name -The generic composition of the name should be noted
How to Dispense SALA Drugs
Medication incidents linked to SALA drug names can pose serious harm to the patients. It is often difficult to detect the medication errors related to SALA drugs as the dispensed medication is presumed to have been the one that is prescribed for the patient.
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• At pharmacy or store while dispensing SALA medications, it should be doubly checked by another pharmacist.
• In wards, nursing staff should doubly check SALA medication before dispensing.
• In case of any doubt, it is mandatory that before dispensing SALA medications, the generic name of the drug to be dispensed should be confirmed from the doctors.
• The list of SALA medications should be made available in all the area from where drugs are being dispensed.
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How to Administer SALA Drugs
List of SALA medications should be available (pasted) in all medication rooms for cross reference. Sound-alike and Look-alike drugs being high-risk medication, the patient should be monitored periodically, after administration of the drug, as this group of medications has high potential for medication error. 12 List of look-alike medications is provided in Annexure 1. 
